Scientists at the University of Rochester have found that restoring the function of tiny lymph vessels in the neck can greatly improve the brain’s waste-clearing system. This breakthrough was achieved ...

The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...

WASHINGTON (AP) — U.S. health officials have endorsed the first blood test that can help diagnose Alzheimer's. The test would help identify patients who may benefit from drugs that can modestly slow ...

The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...

The US Food and Drug Administration approved the first blood test to help diagnose Alzheimer's disease. For all the latest ...

Fujirebio Diagnostics created the test to assess the ratio of two proteins in the blood. The rato is associated with amyloid ...

Shares of Japanese drugmaker Eisai Co. gained after US regulators approved the first blood test to help diagnose Alzheimer’s disease, fueling expectations of an uptick in demand for drugs used to ...

UNITED STATES. (CNN) - The FDA has approved the first blood test to help diagnose Alzheimer’s Disease. The test is for adults ...

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.